|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Frontal lobe perivascular schwannoma显示文摘 | Auer RN Budny J Drake CG Ball M | 1982 | J Neurosurg1982，56，： | 1 |
| 2 | Phase I study of single-agent anti-programmed death-1(MDX-1106)in refractory solid tumors:safety,clinical activity,pharmacodynamics,and immunologic correlates显示文摘 | Brahmer JR Drake CG Wollner I | 2010 | J Clin Oncol2010，28，19： | 1 |
| 3 | Giant fusiform intracranial aneurysms:review of 120 patients treated surgically form 1965 to 1992显示文摘 | Drake CG Peerless SJ | 1997 | J Neurosurg1997，87，： | 1 |
| 4 | Giant fusiform intracranial aneurysms:review of 120 patients treated surgically from 1965 to 1992显示文摘 | Drake CG Peerless SJ | | 0，，02： | 1 |
| 5 | Update:immunological strategies for prostate cancer显示文摘 | DRAKE CG ANTONARAKIS ES | 2010 | Curr Urol Rep2010，11，3： | 1 |
| 6 | Targeting the PD-1/B7- HI(PD-L1) pathway to activate anti-tumor immunity 显示文摘 | Topalian SL Drake CG Pardoll DM | 2012 | Cur- rent opinion in immunology2012，24，2： | 1 |
| 7 | Phase I study of single-agent anti-progTammed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates显示文摘 | Brahmer JR Drake CG Wollner I | 2010 | J Clin Oncol2010，28，19： | 1 |
| 8 | Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines显示文摘 | Zhou G Drake CG Levitsky HI | 2006 | Blood2006，107，2： | 1 |
| 9 | Phase I study of single agent anti-programmed death-1 (MDX-1106) in refractory solid tumors : safety, clinical activity, pharrnacodynamies, and immunologic correlates显示文摘 | Brabmer JR Drake CG Wollner I | 2010 | J Clin Oncol2010，28，19： | 1 |
| 10 | Regrowth of aneurysm sacs from residual neck following aneurysm clipping显示文摘 | Fox AJ Drake CG | 1989 | J Neurosurg1989，70，： | 1 |
| 11 | Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors:safety, clinical activity, pharmacodynamics, and immunologic correlates 显示文摘 | Brahmer JR Drake CG Wollner I | 2010 | J Clin Oncol2010，28，19： | 1 |
| 12 | Targeting the PD-1/B7-II1 ( PD-L1 ) pathway to activate anti-tumor immunity显示文摘 | Topalian SL Drake CG Pardoll DM | 2012 | Curt Opin Immunol2012，24，2： | 1 |
| 13 | Targeting the PD-1/B7-H1 (PD-L1) pathway to activate anti-tumor immunity 显示文摘 | Topalian SL Drake CG Pardoll DM | 2012 | Curr Opin Immunol2012，24，2： | 1 |
| 14 | Cerebral arterioveous malformations considerations for and experience with surgical treatment in 166 cases显示文摘 | | 1979 | Clin Neurosurg1979，26，： | 1 |
| 15 | Timing of aneurysm surgery显示文摘 | Kassell NF Drake CG | 1982 | Neurosurgery1982，10，： | 1 |
| 16 | Phase Ⅰ study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates显示文摘 | Brahmer JR Drake CG Wollner I | 2010 | J Clin Oncol2010，28，19： | 1 |
| 17 | Ipilimumab:an anti-CTLA-4 antibody for metastatic melanoma显示文摘 | Lipson EJ Drake CG | 2011 | Clin Cancer Res2011，17，22： | 1 |
| 18 | Targeting the PD-1/ BT-H1 ( PILL1 ) pathway to activate anti-tumor immunity 显示文摘 | Topalian SL Drake CG Pardoll DM | 2012 | Curr Opin Immunol2012，24，2： | 1 |
| 19 | Failed aneurysm surgery:reoperation in 115 cases显示文摘 | Friedman AH Peerless SJ | 1984 | J Neurosurg1984，61，： | 1 |
| 20 | Cerebral arteriovenous malformations:considerations for and experience with surgical treatment in 166 cases显示文摘 | Drake CG | 1979 | Clin Neurosurg1979，26，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员